XML 61 R52.htm IDEA: XBRL DOCUMENT v3.25.0.1
OVERVIEW AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($)
$ in Millions
 12 Months Ended
Sep. 20, 2024
Oct. 31, 2024
Oct. 31, 2023
Oct. 31, 2022
Oct. 31, 2021
Gain (Loss) on Disposition of Assets [Abstract]          
Proceeds from Divestiture of Businesses   $ 0 $ 50 $ 0  
Net gain on Divestiture of Business   0 43 0  
Goodwill adjustment related to divestiture of business     (13)    
Advertising Expense          
Advertising costs expensed as incurred   49 54 66  
Cash and Cash Equivalents          
Short-term Investments   0 0    
Cash and cash equivalents   1,329 1,590 1,053  
Restricted Cash   3 3 3  
Cash, cash equivalents and restricted cash   1,332 1,593 1,056 $ 1,490
Goodwill and Intangible Assets          
Goodwill impairment   0 0 0  
Impairment of indefinite-lived intangible assets   6 0 0  
Long -Lived Assets          
Impairment of Long-Lived Assets   19 277 0  
Variable Interest Entity          
Assets   11,846 10,763    
Fair Value Disclosures          
Equity Method Investments   0 0    
Carrying Value of Senior Notes   3,345 2,735    
Employee Compensation and Benefits          
Employee compensation and benefits accrued   116 120    
Share-based Payment Arrangement, Noncash Expense [Abstract]          
Share-based compensation expense   130 112 126  
Foreign Currency Translation          
Foreign currency translation net gain (Ioss)   4 2 $ (6)  
In-Process R&D   0 10    
Senior Notes          
Fair Value Disclosures          
Carrying Value of Senior Notes   $ 3,326 $ 2,135    
Accounts Receivable          
Accounts Receivable          
Percent of Accounts receivable from a single customer   No single customer accounted for more than 10 percent of accounts receivable No single customer accounted for more than 10 percent of accounts receivable    
Quoted Prices in Active Markets for Identical Assets (Level 1) | Senior Notes          
Foreign Currency Translation          
Long-term Debt, Fair Value   $ 3,083 $ 1,747    
Variable Interest Entity, Not Primary Beneficiary          
Variable Interest Entity          
Assets   79 82    
Non-US          
Cash and Cash Equivalents          
Cash and cash equivalents   $ 1,313      
Resolution Bioscience, Inc.          
Gain (Loss) on Disposition of Assets [Abstract]          
Net gain on Divestiture of Business     43    
Long -Lived Assets          
Long lived assets held for sale Impairment     $ 270    
BIOVECTRA          
Foreign Currency Translation          
Purchase price for acquisition $ 915        
Minimum          
Goodwill and Intangible Assets          
Finite Lived Intangible Assets Useful Life   2 years      
Minimum | Machinery and Equipment          
Property, Plant and Equipment [Abstract]          
Property, Plant and Equipment, Useful Life   3 years      
Minimum | Software Development          
Property, Plant and Equipment [Abstract]          
Property, Plant and Equipment, Useful Life   3 years      
Maximum          
Goodwill and Intangible Assets          
Finite Lived Intangible Assets Useful Life   15 years      
Maximum | Machinery and Equipment          
Property, Plant and Equipment [Abstract]          
Property, Plant and Equipment, Useful Life   10 years      
Maximum | Software Development          
Property, Plant and Equipment [Abstract]          
Property, Plant and Equipment, Useful Life   5 years